First comparison between artificial intelligence-guided coronary computed tomography angiography versus single-photon emission computed tomography testing for ischemia in clinical practice – PubMed

AI-powered CCTA is a viable alternative to SPECT for detecting myocardial ischemia in patients with low- to intermediate-risk coronary artery disease, with significant positive and negative correlation in results. For patients who underwent confirmatory invasive angiography, the results of AI-CCTA a …

Read the full article here

Source: pubmed.ncbi.nlm.nih.gov

Categories: Cardiologists, General Medicine News

Tweets with this article

Matthew Budoff MD

Another @ronaldkarlsberg paper showing CCTA is superior to SPECT, especially in women. Why anyone still uses SPECT, especially in women, to diagnose CAD is beyond my understanding and the science. High radiation, low diagnostic accuracy. Time to move on https://t.co/zVPXYf8PJk

‘A victory for TAVR’: How treatment impacts elderly patients in their last year of life

New research out of Denmark explored how undergoing TAVR may or may not influence the final year of a patient’s life.

ACC Media Center January 6, 2025

Vascular Disease Patient Information Page: Renal artery stenosis – Natalie Rilo, Shivani Lam, Bryan J Wells, 2025

The kidneys are respon sible for regulating the body’s fluid balance and blood pressure. Renal artery stenosis (RAS) involves a narrowing (stenosis) of the arteries…

VascularMedicine January 6, 2025

Incarceration is associated with higher mortality after… : Journal of Trauma and Acute Care Surgery

analysis of incarcerated trauma patients to date and investigates whether incarceration status is an independent risk factor for poor outcomes after trauma for US adults.…

Elliott R Haut, MD, PhD January 6, 2025

Four Sussex hospitals ask staff and visitors to wear masks

The advice comes as flu cases rise at sites in Brighton, Chichester, Worthing and Haywards Heath.

Hany Ragy January 6, 2025

2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association | Stroke

AIM: The “2024 Guideline for the Primary Prevention of Stroke” replaces the 2014 “Guidelines for the Primary Prevention of Stroke.” This updated guideline is intended…

Stroke AHA/ASA January 6, 2025

Coding Corner: How to Use New ASCVD Risk Assessment and Management Codes – American College of Cardiology

The Centers for Medicare and Medicaid Services (CMS) created two new G codes in the 2025 Medicare Physician Fee Schedule final rule that will provide…

ACC Advocacy, CV Quality January 6, 2025

Advanced Echocardiography techniques in structural heart disease and heart failure

In this workshop we will highlight the use of 3D echocardiography in special clinical settings from guiding medical therapy to mechanical support.

Jan Verwerft January 6, 2025

High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC

Guidance on high-risk PCI in patients with severely reduced left ventricular function not suitable for CABG.

ᗰIᖇᐯᗩT مرفت الأصنج January 6, 2025

The Case for Ruben Amorim | Guardiola’s Changes | Protecting Assets | Maresca Lowers the Ante

1. Ruben Amorim took a team without World Class Players to Anfield in arguably Manchester United’s Worst Moment and played well. United were for the…

January 6, 2025

Dr. Perin Leads DREAM-HF Trial – Demonstrating the Life-Saving Potential of Cell Therapy

Dr. Emerson C. Perin, Medical Director at The Texas Heart Institute, has been highlighted as the lead investigator in the landmark DREAM-HF trial, which demonstrated…

TexasHeartInstitute January 6, 2025

Related Articles